A MULTIDISCIPLINARY QUALITY INITIATIVE TO ADDRESS DELAYS IN INITIATING POST-OPERATIVE RADIOTHERAPY IN HEAD AND NECK CANCER PATIENTS

IF 5.3 1区 医学 Q1 ONCOLOGY
Madette Galapin , Antoine Eskander , Danny Enepekides , Kevin Higgins , Irene Karam , Ian Poon , Andrew Bayley
{"title":"A MULTIDISCIPLINARY QUALITY INITIATIVE TO ADDRESS DELAYS IN INITIATING POST-OPERATIVE RADIOTHERAPY IN HEAD AND NECK CANCER PATIENTS","authors":"Madette Galapin ,&nbsp;Antoine Eskander ,&nbsp;Danny Enepekides ,&nbsp;Kevin Higgins ,&nbsp;Irene Karam ,&nbsp;Ian Poon ,&nbsp;Andrew Bayley","doi":"10.1016/S0167-8140(25)04746-2","DOIUrl":null,"url":null,"abstract":"<div><h3>Purpose:</h3><div>The American College of Surgeons Commission on Cancer’s (ACS/CoC) head and neck (HN) quality metric requires post-operative radiotherapy (PORT) initiation within 42 days from surgery. A 2021/2022 quality improvement (QI) audit revealed only 43% of our patients met this metric. Root cause analysis suggested radiation oncologist (RO) assessment ≤21 days post-op supports timely PORT. This QI initiative aimed to increase adherence from 43% to 70% by the end of 2024.</div></div><div><h3>Materials and Methods:</h3><div>This multidisciplinary QI initiative (registered with our institution, REB not required) implemented a new standard operating procedure. Included were patients with mucosal and skin squamous cell carcinomas (SCC), melanomas, salivary gland and other high-risk skin carcinomas undergoing surgery &amp; PORT (January - December 2024), excluding those with prior HN radiotherapy. The intervention involved: 1) HN clinical specialist radiation therapist (CSRT) identifying relevant patients and informing RO of PORT goal dates, and 2) an order for a 3-week post-op RO follow-up (FU) booked via the computerized provider order entry system. Measures included: percentage of patients initiating PORT ≤ 42 days (outcome), seeing RO ≤21 days post-op (process), and initiating PORT ≤42 days with rushed planning process (&lt;14 days) from simulation to treatment (balancing). Quarterly updates maintained project momentum through team feedback and addressing concerns.</div></div><div><h3>Results:</h3><div>Of the 135 patients included, 62 (46%) began PORT ≤42. Among those with SCC, timely PORT was seen in 50/92 (54%) compared to 12/43 (28%) with non-SCC histology. Timely PORT in 2024 was variable with an improvement of 12/26 (46%) in Q1 to 21/39 (54%) in Q4, but 13/33 (39%) in Q2 and 16/37 (43%) in Q3. RO assessment ≤ 21 days post-op occurred in 54/135 (40%) patients. This improved from 10/26 (38%) in Q1 to 17/39 (44%) in Q4 but varied with 14/33 (47%) in Q2 and 13/37 (35%) in Q3. Among patients with timely RO assessment, 38/54 (70%) achieved timely PORT, increasing from 7/10 (70%) in Q1 to 14/17 (82%) in Q4, but varied with 10/14 (71%) in Q2 and 7/13 (54%) in Q3. Rushed planning increased from 4/12 (33%) in Q1 to 5/13 (38%) in Q2 and 10/16 (63%) in Q3 but decreased to 8/21 (38%) in Q4. For the 73 patients with delayed PORT, main causes were: care coordination issues (56%), post-op complications (32%), and other (12%). Analysis revealed 70% of delays were unavoidable, including post-op complications, wound healing issues, delayed referrals from non-cancer centre surgeons, and patient-requested delays.</div></div><div><h3>Conclusions:</h3><div>The QI intervention improved adherence to the ACS/ CoC metric from 43% to 46%. This fell short of the 70% goal which can be attributed to 70% of delays deemed as unavoidable. Future sustainable interventions include dedicated patient navigation, automated FU booking, and enhanced care pathway visualization.</div></div>","PeriodicalId":21041,"journal":{"name":"Radiotherapy and Oncology","volume":"210 ","pages":"Pages S37-S38"},"PeriodicalIF":5.3000,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Radiotherapy and Oncology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0167814025047462","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Purpose:

The American College of Surgeons Commission on Cancer’s (ACS/CoC) head and neck (HN) quality metric requires post-operative radiotherapy (PORT) initiation within 42 days from surgery. A 2021/2022 quality improvement (QI) audit revealed only 43% of our patients met this metric. Root cause analysis suggested radiation oncologist (RO) assessment ≤21 days post-op supports timely PORT. This QI initiative aimed to increase adherence from 43% to 70% by the end of 2024.

Materials and Methods:

This multidisciplinary QI initiative (registered with our institution, REB not required) implemented a new standard operating procedure. Included were patients with mucosal and skin squamous cell carcinomas (SCC), melanomas, salivary gland and other high-risk skin carcinomas undergoing surgery & PORT (January - December 2024), excluding those with prior HN radiotherapy. The intervention involved: 1) HN clinical specialist radiation therapist (CSRT) identifying relevant patients and informing RO of PORT goal dates, and 2) an order for a 3-week post-op RO follow-up (FU) booked via the computerized provider order entry system. Measures included: percentage of patients initiating PORT ≤ 42 days (outcome), seeing RO ≤21 days post-op (process), and initiating PORT ≤42 days with rushed planning process (<14 days) from simulation to treatment (balancing). Quarterly updates maintained project momentum through team feedback and addressing concerns.

Results:

Of the 135 patients included, 62 (46%) began PORT ≤42. Among those with SCC, timely PORT was seen in 50/92 (54%) compared to 12/43 (28%) with non-SCC histology. Timely PORT in 2024 was variable with an improvement of 12/26 (46%) in Q1 to 21/39 (54%) in Q4, but 13/33 (39%) in Q2 and 16/37 (43%) in Q3. RO assessment ≤ 21 days post-op occurred in 54/135 (40%) patients. This improved from 10/26 (38%) in Q1 to 17/39 (44%) in Q4 but varied with 14/33 (47%) in Q2 and 13/37 (35%) in Q3. Among patients with timely RO assessment, 38/54 (70%) achieved timely PORT, increasing from 7/10 (70%) in Q1 to 14/17 (82%) in Q4, but varied with 10/14 (71%) in Q2 and 7/13 (54%) in Q3. Rushed planning increased from 4/12 (33%) in Q1 to 5/13 (38%) in Q2 and 10/16 (63%) in Q3 but decreased to 8/21 (38%) in Q4. For the 73 patients with delayed PORT, main causes were: care coordination issues (56%), post-op complications (32%), and other (12%). Analysis revealed 70% of delays were unavoidable, including post-op complications, wound healing issues, delayed referrals from non-cancer centre surgeons, and patient-requested delays.

Conclusions:

The QI intervention improved adherence to the ACS/ CoC metric from 43% to 46%. This fell short of the 70% goal which can be attributed to 70% of delays deemed as unavoidable. Future sustainable interventions include dedicated patient navigation, automated FU booking, and enhanced care pathway visualization.
一项多学科质量倡议,以解决头颈癌患者术后放疗开始延迟的问题
目的:美国外科医师学会癌症委员会(ACS/CoC)头颈部(HN)质量指标要求术后放疗(PORT)在手术后42天内开始。2021/2022年质量改进(QI)审计显示,只有43%的患者符合这一指标。根本原因分析建议放射肿瘤学家(RO)评估≤术后21天支持及时PORT。该QI计划旨在到2024年底将依从性从43%提高到70%。材料和方法:这个多学科QI倡议(在我们机构注册,不需要REB)实施了一个新的标准操作程序。纳入了2024年1月- 12月接受PORT手术的粘膜和皮肤鳞状细胞癌(SCC)、黑色素瘤、唾液腺和其他高危皮肤癌患者,不包括既往HN放疗患者。干预包括:1)HN临床专科放射治疗师(CSRT)识别相关患者并通知RO PORT目标日期,2)通过计算机化提供者订单输入系统预订3周的RO术后随访(FU)。测量包括:从模拟到治疗(平衡),启动PORT≤42天(结果)、术后RO≤21天(过程)、启动PORT≤42天且匆忙规划过程(<;14天)的患者百分比。季度更新通过团队反馈和解决问题来保持项目的动力。结果:纳入的135例患者中,62例(46%)开始PORT≤42。在SCC患者中,及时PORT为50/92(54%),而非SCC患者为12/43(28%)。2024年的及时PORT是可变的,第一季度为12/26(46%),第四季度为21/39(54%),第二季度为13/33(39%),第三季度为16/37(43%)。术后≤21天的RO评估发生在54/135(40%)患者中。这一比例从第一季度的10/26(38%)提高到第四季度的17/39(44%),但在第二季度和第三季度分别为14/33(47%)和13/37(35%)。在及时进行RO评估的患者中,38/54(70%)达到了及时的PORT,从第一季度的7/10(70%)增加到第四季度的14/17(82%),但第二季度的10/14(71%)和第三季度的7/13(54%)有所不同。匆忙的计划从第一季度的4/12(33%)上升到第二季度的5/13(38%)和第三季度的10/16(63%),但在第四季度下降到8/21(38%)。73例延迟PORT患者的主要原因是:护理协调问题(56%)、术后并发症(32%)和其他(12%)。分析显示,70%的延误是不可避免的,包括术后并发症、伤口愈合问题、非癌症中心外科医生的延迟转诊以及患者要求的延误。结论:QI干预将ACS/ CoC指标的依从性从43%提高到46%。这低于70%的目标,因为70%的延误被认为是不可避免的。未来可持续的干预措施包括专门的患者导航、自动FU预约和增强的护理路径可视化。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Radiotherapy and Oncology
Radiotherapy and Oncology 医学-核医学
CiteScore
10.30
自引率
10.50%
发文量
2445
审稿时长
45 days
期刊介绍: Radiotherapy and Oncology publishes papers describing original research as well as review articles. It covers areas of interest relating to radiation oncology. This includes: clinical radiotherapy, combined modality treatment, translational studies, epidemiological outcomes, imaging, dosimetry, and radiation therapy planning, experimental work in radiobiology, chemobiology, hyperthermia and tumour biology, as well as data science in radiation oncology and physics aspects relevant to oncology.Papers on more general aspects of interest to the radiation oncologist including chemotherapy, surgery and immunology are also published.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信